AAAAAA
Results:
1-14
|
Results: 14
Authors:
ALMROTH A
LJUNG G
EKLUND T
NORDGREN H
KALAFATIDIS D
RINGQVIST I
NILSSON S
Citation: A. Almroth et al., VALUE OF SEXTANT BIOPSIES IN THE ASSESSMENT OF LOCAL CURE FOLLOWING EXTERNAL-BEAM RADIOTHERAPY OF PROSTATIC ADENOCARCINOMA, Scandinavian journal of urology and nephrology, 32(2), 1998, pp. 111-115
Authors:
NILSSON S
ESSAND M
LOGDAHL P
LARSON A
NORDGREN H
JUHLIN C
Citation: S. Nilsson et al., E4, A NEW MONOCLONAL-ANTIBODY IDENTIFYING A HUMAN PROSTATIC CELL-SURFACE ANTIGEN, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(6), 1997, pp. 395-403
Authors:
WARNBERG F
NORDGREN H
HELMBERG L
BERGH J
Citation: F. Warnberg et al., DUCTAL CARCINOMA IN-SITU OF THE BREAST, AN EVALUATION OF A NEW HISTOPATHOLOGICAL CLASSIFICATION-SYSTEM, European journal of cancer, 33, 1997, pp. 880-880
Authors:
LILJEGREN G
LINDGREN A
BERGH J
NORDGREN H
TABAR L
HOLMBERG L
Citation: G. Liljegren et al., RISK-FACTORS FOR LOCAL RECURRENCE AFTER CONSERVATIVE TREATMENT IN STAGE-I BREAST-CANCER - DEFINITION OF A SUBGROUP NOT REQUIRING RADIOTHERAPY, Annals of oncology, 8(3), 1997, pp. 235-241
Authors:
SJOGREN S
INGANAS M
NORBERG T
LINDGREN A
NORDGREN H
HOLMBERG L
BERGH J
Citation: S. Sjogren et al., THE P53 GENE IN BREAST-CANCER - PROGNOSTIC VALUE OF COMPLEMENTARY-DNASEQUENCING VERSUS IMMUNOHISTOCHEMISTRY, Journal of the National Cancer Institute, 88(3-4), 1996, pp. 173-182
Authors:
NORDGREN H
LINDGREN A
BERGH J
Citation: H. Nordgren et al., THE P53 GENE IN BREAST-CANCER - PROGNOSTIC VALUE OF COMPLEMENTARY-DNASEQUENCING VERSUS IMMUNOHISTOCHEMISTRY - RESPONSE, Journal of the National Cancer Institute, 88(20), 1996, pp. 1500-1500
Authors:
STATTIN P
BERGH A
KARLBERG L
NORDGREN H
DAMBER JE
Citation: P. Stattin et al., P53 IMMUNOREACTIVITY AS PROGNOSTIC MARKET FOR CANCER-SPECIFIC SURVIVAL IN PROSTATE-CANCER, European urology, 30(1), 1996, pp. 65-72
Authors:
STATTIN P
DAMBER JE
KARLBERG L
NORDGREN H
BERGH A
Citation: P. Stattin et al., BCL-2 IMMUNOREACTIVITY IN PROSTATE TUMORIGENESIS IN RELATION TO PROSTATIC INTRAEPITHELIAL NEOPLASIA, GRADE, HORMONAL STATUS, METASTATIC GROWTH AND SURVIVAL, Urological research, 24(5), 1996, pp. 257-264
Authors:
NORBERG T
JANSSON T
SJOGREN S
MARTENSSON C
ANDREASSON I
FJALLSKOG ML
LINDMAN H
NORDGREN H
LINDGREN A
HOLMBERG L
BERGH J
Citation: T. Norberg et al., OVERVIEW ON HUMAN BREAST-CANCER WITH FOCUS ON PROGNOSTIC AND PREDICTIVE FACTORS WITH SPECIAL ATTENTION ON THE TUMOR-SUPPRESSOR GENE P53, Acta oncologica, 35(5), 1996, pp. 96-102
Authors:
EDGREN M
WESTLIN JE
LETOCHA H
NORDGREN H
KALKNER KM
NILSSON S
Citation: M. Edgren et al., ESTRAMUSTINE-BINDING PROTEIN (EMBP) IN RENAL-CELL CARCINOMA IMMUNOHISTOCHEMISTRY, IMMUNOSCINTIGRAPHY AND IN-VITRO ESTRAMUSTINE EFFECTS, Acta oncologica, 35(4), 1996, pp. 483-488
Authors:
ASTROM GK
AHLSTROM HK
NORDGREN H
CIRAY I
BERGH J
Citation: Gk. Astrom et al., HORMONAL RECEPTOR ANALYSIS OF SKELETAL METASTASES FROM BREAST-CARCINOMA, Radiology, 201, 1996, pp. 1256-1256
Authors:
NORDGREN H
FREYSCHUSS U
PERSSON B
Citation: H. Nordgren et al., BLOOD-PRESSURE RESPONSE TO PHYSICAL EXERCISE IN HEALTHY ADOLESCENTS AND ADOLESCENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS, Clinical science, 86(4), 1994, pp. 425-432
Authors:
EKLOV S
FUNA K
NORDGREN H
OLOFSSON A
KANZAKI T
MIYAZONO K
NILSSON S
Citation: S. Eklov et al., LACK OF THE LATENT TRANSFORMING GROWTH-FACTOR-BETA BINDING-PROTEIN INMALIGNANT, BUT NOT BENIGN PROSTATIC TISSUE, Cancer research, 53(13), 1993, pp. 3193-3197
Authors:
RAHME H
NORDGREN H
HAMBERG H
WESTERBERG CE
Citation: H. Rahme et al., THE SUBACROMIAL BURSA AND THE IMPINGEMENT SYNDROME - A CLINICAL AND HISTOLOGICAL STUDY OF 30 CASES, Acta orthopaedica Scandinavica, 64(4), 1993, pp. 485-488
Risultati:
1-14
|